Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy

Clinical Infectious Diseases

Volumn 44, Issue 12, 2007, Pages 1593-1601

  Vekemans, M ^a,c   Robinson, J ^d   Georgala, A ^a   Heymans, C ^a   Muanza, F ^a   Paesmans, M ^a   Klastersky, J ^a   Barette, M ^a   Meuleman, N ^a   Huet, F ^a   Calandra, T ^d   Costantini, S ^b   Ferrant, A ^b   Mathissen, F ^e   Axelsen, M ^e   Marchetti, O ^d   Aoun, M ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e NatImmune A/S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MANNOSE BINDING LECTIN;

ACUTE LEUKEMIA; ADULT; AGED; ALGORITHM; ARTICLE; BACTEREMIA; CANCER CHEMOTHERAPY; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEBRILE NEUTROPENIA; FEMALE; FISHER EXACT TEST; GENOTYPE; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFECTION; KAPLAN MEIER METHOD; LOG RANK TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MYCOSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; SEPSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DISEASE SUSCEPTIBILITY; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; NEUTROPENIA; PNEUMONIA; PROSPECTIVE STUDIES; RISK FACTORS; SEPSIS;

EID: 34249898941     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/518171     Document Type: Article

References (20)

1. Kawasaki N, Kawasaki T, Yamashina I. Isolation and characterization of a mannan-binding protein from human serum. J Biochem (Tokyo) 1983; 94:937-47.
2. Wild J, Robinson D, Winchester B. Isolation of mannose-binding proteins from human and rat liver. Biochem J 1983; 210:167-74.
3. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992; 176:1497-502.
4. Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155:3013-20.
5. Madsen HO, Garred P, Kurtzhals JA, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein, Immunogenetics 1994; 40:37-44.
6. Lipscombe RJ, Sumiya M, Hill AV, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992; 1:709-15.
7. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet 1989; 2:1236-9.
8. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ 1997; 314:1229-32.
9. Kielgast S, Thiel S, Henriksen TB, Bjerke T, Olsen J, Jensenius JC. Umbilical cord mannan-binding lectin and infections in early childhood. Scand J Immunol 2003; 57:167-72.
10. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358:637-8.
11. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
12. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328-40.
13. Thiel S, Moller-Kristensen M, Jensen L, Jensenius JC. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002; 205:446-54.
14. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods 2000; 241:33-42.
15. Steffensen R, Hoffmann K, Varming K. Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods 2003; 278:191-9.
16. Horiuchi T, Gondo H, Miyagawa H, et al. Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCT. Genes Immun 2005; 6:162-6.
17. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99:3524-9.
18. Kilpatrick DC, Mclintock LA, Allan EK, et al. No strong relationship between mannan binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003; 134:279-4.
19. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358:614-8.
20. Bergmann OJ, Christiansen M, Laursen I, et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003; 70:91-7.